Physician
Infectious Disease
Dr. John Campbell, MD
|
|
Give Review
John Campbell is an expert in the field of Infectious Disease. He studied medicine at Washington University School of Medicine in St. Louis. He received awards:"America's Top Doctors", "CMS Meaningful Use Stage 1 Certification" and "St. Louis Magazine: Top Doctors". John Campbell is a published doctor as well. He has 26 publications published. The latest was: Basic fibroblast growth factor expression as a predictor of prognosis in pediatric high-grade gliomas. Dr. John Campbell accepts Medicare payments and is registered with Medicare.gov.
Publications
- Invasive aspergillosis due to Neosartorya udagawae.
- Experimental determination and system level analysis of essential genes in Escherichia coli MG1655.
- Escherichia coli FadR positively regulates transcription of the fabB fatty acid biosynthetic gene.
- Bacterial fatty acid biosynthesis: targets for antibacterial drug discovery.
- Basic fibroblast growth factor expression as a predictor of prognosis in pediatric high-grade gliomas.
- Evidence for the involvement of carbonic anhydrase and urease in calcium carbonate formation in the gravity-sensing organ of Aplysia californica.
- Mitochondrial ammonia metabolism and the proton-neutral theory of hepatic ammonia detoxication.
- Contrast media costs can be reduced still more.
- Proliferation index as a predictor of prognosis in malignant gliomas of childhood.
- Morbidity and mortality of incontinence surgery in elderly women: an analysis of Medicare data.
- The relationship between TP53 mutations and overexpression of p53 and prognosis in malignant gliomas of childhood.
- High-grade astrocytomas in children: radiologically complete resection is associated with an excellent long-term prognosis.
- Hallucinations associated with itraconazole therapy.
- Physiological responses of beef cattle to Gulf Coast tick (Acari: Ixodidae) infestations.
- Living with genome instability: the adaptation of phytoplasmas to diverse environments of their insect and plant hosts.
- FlhD/FlhC is a regulator of anaerobic respiration and the Entner-Doudoroff pathway through induction of the methyl-accepting chemotaxis protein Aer.
- Expression of Vibrio harveyi acyl-ACP synthetase allows efficient entry of exogenous fatty acids into the Escherichia coli fatty acid and lipid A synthetic pathways.
- Genome-scale identification of conditionally essential genes in E. coli by DNA microarrays.
- From genetic footprinting to antimicrobial drug targets: examples in cofactor biosynthetic pathways.
- Gene array analysis of Yersinia enterocolitica FlhD and FlhC: regulation of enzymes affecting synthesis and degradation of carbamoylphosphate.
- Growth of Escherichia coli MG1655 on LB medium: determining metabolic strategy with transcriptional microarrays.
- Growth of Escherichia coli MG1655 on LB medium: monitoring utilization of sugars, alcohols, and organic acids with transcriptional microarrays.
- Growth of Escherichia coli MG1655 on LB medium: monitoring utilization of amino acids, peptides, and nucleotides with transcriptional microarrays.
- A new Escherichia coli metabolic competency: growth on fatty acids by a novel anaerobic beta-oxidation pathway.
- The enigmatic Escherichia coli fadE gene is yafH.
Schools
Washington University In St Louis School Of Medicine
Barnes Hospital Wash University
University Texas Health Scis Center
Wash University
Washington University
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
Awards
- America's Top Doctors
- CMS Meaningful Use Stage 1 Certification
- St. Louis Magazine: Top Doctors
Education
-
University of Texas Health Science Center -
Washington University - Barnes-Jewish Hospital -
Washington University School of Medicine in St. Louis
Hospital
-
St. Luke's Hospital
Drug Facts
| NPI NUMBER | 1417901232 | |
| NPPES Provider LastName | CAMPBELL | |
| NPPES Provider FirstName | JOHN | |
| NPPES Provider ZIPCode | 495084994 | |
| NPPES Provider State | MI | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 64565.0 | |
| Distinct Opioid Count | 14.0 | |
| Opioid Claim Count | 3078.0 | |
| Percent Opioid Claims | 4.77 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1417901232 |
| Last Name Of The Provider | CAMPBELL |
| First Name Of The Provider | JOHN |
| View All |
Similar Doctors
|
Dr. David O. McCrary, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Matthew L. German, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Leon R. Robison, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Joseph M. Fritz, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. David W. Ortbals, MD |
|
|
Dr. Krunal D. Raval, MD |